ask="31.97"
ask_size="700"
average_daily_volume="308184"
bid="N/A"
bid_size="N/A"
book_value="6.19"
change="+0.16"
change_from_200_day_moving_average="1.49"
change_from_50_day_moving_average="0.60"
change_from_52_week_high="-6.90"
change_From_52_week_low="18.43"
change_in_percent="+0.50%"
close="32.02"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.83"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31803000"
high="32.42"
high_52_weeks="38.92"
last_trade_date="2/10/2017"
last_trade_price="32.02"
last_trade_size="8473"
last_trade_time="4:00pm"
low="31.94"
low_52_weeks="13.59"
market_capitalization="1.66B"
moving_average_200_day="30.53"
moving_average_50_day="31.42"
name="Theravance Biopharma
Inc. - Or"
notes="N/A"
one_year_target_price="34.71"
open="32.09"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+4.87%"
percent_change_from_50_day_moving_average="+1.92%"
percent_change_from_52_week_high="-17.73%"
percent_change_from_52_week_low="+135.61%"
previous_close="31.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.14"
price_per_sales="35.32"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="18.07"
stock_exchange="NGM"
symbol="TBPH"
volume="95550"
weeks_range_52="13.59 - 38.92"
